-
Featured Authors
Health
Category Archives: Health
Latest From Health
Biotechnology Innovation: Impact of Health Reform and Deficit Control
By Alyson Pusey, BIO. With many governors around the country facing budget shortfalls, “the action is all in the states” in terms of health care cuts and cost-savings solutions, according to panelists participating. The current fiscal environment has forced cash-strapped states to look at their Medicaid programs for ways to rein in costs, and according to panelists, state lawmakers will continue to do so for the foreseeable future. For example, as a result of the Read More >
A Center for Advancing Translational Science can spur new therapies
Sometimes, spurring the development of new drugs and therapies can be like trying to a cross shark-infested water without a bridge, Dr. Francis Collins, director of NIH, said during his keynote at the Translational Research Forum during the 2011 BIO International Convention. However, during a time of unprecedented scientific advances, but increasingly limited resources, the public and private sectors must learn to combine their respective efforts to relieve human suffering. Dr. Collins gave a rapid Read More >
Health
Leave a comment
Email This Post
Tags: 2011 BIO International Convention, American Clean Energy and Security Act, BIO International Convention, Cures Acceleration Network, FDA, Food and Drug Administration, National Center for Advancing Translational Science, National Institute of Health, NIH, Phase Zero, translational research
Tags: 2011 BIO International Convention, American Clean Energy and Security Act, BIO International Convention, Cures Acceleration Network, FDA, Food and Drug Administration, National Center for Advancing Translational Science, National Institute of Health, NIH, Phase Zero, translational research
NIH Broadening Our Vision of Global Health
Angie Drakulich, part of our BIO Official Bloggers Program, attended yesterday’s Francis Collins speech: For starters, Collins pointed out that recent scientific advances such as RNAi, small molecule screening, and genomics of pathogens, are allowing researchers and drug developers to fight infectious diseases. As a result, the pharma and healthcare sectors are able to look beyond the Big 3 diseases (HIV/AIDS, TB, and malaria) and pay more attention to neglected diseases such as dengue, as Read More >
Sickle Cell Anemia: Three ways to help end it
Sickle Cell Anemia is the most common genetic disease in the United States. It affects more than 80,000 people in America and the trait for the disease is known to be carried by one in 12 African Americans. For those living with the disease, suffering from a sickle cell crisis can be debilitating, reducing a person into a state of intense pain, which often means trips to the hospital that typically last six days. There Read More >
Podcast: Dr. Hervé Tettelin on vaccine development
Dr. Tettelin, with the University of Maryland School of Medicine in the Institute for Genome Sciences, discusses his research in reverse vaccinology and as a pioneer of the pan-genome concept. He also discusses how DNA sequencing is evolving and how that impacts vaccine development. Download the podcast
